Cargando…

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma

The prevalence and mortality of hepatocellular carcinoma (HCC) are still increasing. This study aimed to identify potential therapeutic targets related to patient prognosis. Data were downloaded from TCGA, GSE25097, GSE36376, and GSE76427 datasets. Differential analysis and enrichment analysis were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Kaihua, Li, Xiaoting, Mo, Jianwen, Chen, Yixuan, Huang, Chengyu, Li, Ting, Luo, Tianjian, Zhong, Zhijian, Jiang, Yongqiang, Yang, Dengfeng, Mo, Weiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167346/ https://www.ncbi.nlm.nih.gov/pubmed/37156819 http://dx.doi.org/10.1038/s41598-023-34261-1

Ejemplares similares

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

HSF1 promotes CD69(+) Treg differentiation to inhibit colitis progression
por: Yu, Lei, et al.
Publicado: (2023)

TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer
por: Zou, Xiong, et al.
Publicado: (2022)

Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma
por: Mo, Zhijing, et al.
Publicado: (2016)

METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment
por: Wang, Lei, et al.
Publicado: (2023)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2019)

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production
por: Yu, Lei, et al.
Publicado: (2018)

Diagnostic Value of CD25, CD69, and CD134 on Tuberculosis-Specific Antigen-Stimulated CD4+ T Cells for Tuberculous Pleurisy
por: Shi, Hanlu, et al.
Publicado: (2023)

CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma
por: Su, Qiuming, et al.
Publicado: (2022)

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
por: Yoo, Wonbeak, et al.
Publicado: (2023)

CD147 overexpression may serve as a promising diagnostic and prognostic marker for gastric cancer: evidence from original research and literature
por: Hu, Chenghao, et al.
Publicado: (2017)

The Autophagy Related Gene CHAF1B Is a Relevant Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma
por: Zhang, Zunni, et al.
Publicado: (2021)

Methylation factors as biomarkers of fibromyalgia
por: Huang, Chengyu, et al.
Publicado: (2023)

Enhanced Antitumor Immunity in Mice Deficient in CD69
por: Esplugues, Enric, et al.
Publicado: (2003)

CD69 Does Not Affect the Extent of T Cell Priming
por: Alari-Pahissa, Elisenda, et al.
Publicado: (2012)

Ancient genes can be served as pan‐cancer diagnostic and prognostic biomarkers
por: Ji, Xiangwen, et al.
Publicado: (2020)

Transmembrane protein CD69 acts as an S1PR1 agonist
por: Chen, Hongwen, et al.
Publicado: (2023)

Transmembrane protein CD69 acts as an S1PR1 agonist
por: Chen, Hongwen, et al.
Publicado: (2023)

TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Cheng, Sheng, et al.
Publicado: (2023)

Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma
por: Li, Jianwen, et al.
Publicado: (2022)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma
por: Li, Hong-Tao, et al.
Publicado: (2020)

CD69 is expressed on platelets and mediates platelet activation and aggregation
Publicado: (1990)

Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters
por: Chen, Zhen-Yan, et al.
Publicado: (2020)

Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
por: Persson, Jonas, et al.
Publicado: (2021)

MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma
por: Yang, Xiaohui, et al.
Publicado: (2020)

Myelin and lymphocyte protein serves as a prognostic biomarker and is closely associated with the tumor microenvironment in the nephroblastoma
por: Su, Cheng, et al.
Publicado: (2022)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma
por: Cai, Jie, et al.
Publicado: (2016)

Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
por: Huang, Yugang, et al.
Publicado: (2021)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

CD49b/CD69-Dependent Generation of Resting T Helper Cell Memory
por: Hanazawa, Asami, et al.
Publicado: (2013)

Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma
por: Han, Yawei, et al.
Publicado: (2022)

CD148 Serves as a Prognostic Marker of Gastric Cancer and Hinders Tumor Progression by Dephosphorylating EGFR
por: Sun, Yiting, et al.
Publicado: (2020)

Dionysus in 69 /
Publicado: (1970)

Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema
por: Fujita, Tetsuo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rpd7noib4lugrp50p5l052vjf8